Bristol Myers boosts cancer drug portfolio with $4.1 billion Turning Point deal

Go back to Bristol Myers boosts cancer drug portfolio with $4.1 billion Turning Point deal
Bristol-Myers Squibb (NYSE: BMY) Delayed: 59.87 +0.28 (0.47%)
Previous Close $59.59    52 Week High $77.12 
Open $59.45    52 Week Low $49.03 
Day High $59.87    P/E 38.88 
Day Low $59.01    EPS $1.54 
Volume 2,089,800       

TORREYPINES THERA (NASDAQ: TPTX) Delayed: 76.01 --0 (-0%)
Previous Close $76.01    52 Week High $0.69 
Open $0.10    52 Week Low $0.07 
Day High $76.01    P/E N/A 
Day Low $76.01    EPS $-0.90 
Volume 11,307